ARKG vs. HELX ETF Comparison

Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to Franklin Genomic Advancements ETF (HELX)

ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.31

Average Daily Volume

2,334,742

Number of Holdings ^*

* may have additional holdings in another (foreign) market

HELX

Franklin Genomic Advancements ETF

HELX Description

Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

Grade (RS Rating)

Last Trade

$29.32

Average Daily Volume

862

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	ARKG	HELX
30 Days	-19.23%	-10.22%
60 Days	-25.84%	-6.90%
90 Days	-19.31%	-1.37%
12 Months	-22.46%	-3.29%

15 Overlapping Holdings

Symbol	Grade	Weight in ARKG	Weight in HELX	Overlap
BEAM	F	3.87%	0.7%	0.7%
CRSP	F	7.23%	0.86%	0.86%
EXAS	D	5.67%	2.17%	2.17%
IONS	D	3.92%	2.28%	2.28%
MRNA	B	2.76%	1.99%	1.99%
NTLA	F	3.97%	1.38%	1.38%
NTRA	B	0.53%	2.78%	0.53%
PACB	F	2.63%	0.08%	0.08%
REGN	C	1.1%	4.43%	1.1%
RXRX	F	5.36%	0.4%	0.4%
SDGR	F	4.55%	0.54%	0.54%
TWST	D	6.08%	0.72%	0.72%
TXG	F	3.92%	0.13%	0.13%
VCYT	F	2.69%	0.15%	0.15%
VRTX	C	2.38%	4.55%	2.38%

ARKG Overweight 23 Positions Relative to HELX

Symbol	Grade	Weight
DNA	F	3.67%
ARCT	F	3.65%
CDNA	F	3.54%
TDOC	F	3.22%
ACCD	D	3.21%
NRIX	B	2.99%
VEEV	D	2.61%
ADPT	F	1.83%
MASS	F	1.72%
VERV	F	1.61%
QSI	F	1.53%
INCY	F	1.49%
ABSI	B	1.32%
CMPS	F	1.31%
PATH	F	1.19%
PRME	F	1.17%
AMGN	B	0.92%
CERS	F	0.92%
RPTX	F	0.7%
BFLY	F	0.7%
PSNL	F	0.57%
GH	F	0.44%
NVDA	B	0.22%

ARKG Underweight 40 Positions Relative to HELX

Symbol	Grade	Weight
MEDP	C	-7.59%
TMO	C	-4.72%
KRYS	A	-4.36%
LLY	C	-4.15%
DHR	C	-3.94%
BRKR	D	-3.37%
CRL	D	-2.45%
AZN	A	-2.41%
CDNS	C	-2.35%
A	C	-2.21%
CTVA	B	-2.19%
RCKT	F	-2.17%
QGEN	D	-1.8%
BNTX	F	-1.63%
SRPT	D	-1.57%
ICLR	D	-1.53%
FDMT	D	-1.45%
ALNY	F	-1.32%
VYGR	F	-1.23%
IQV	C	-1.16%
AZTA	D	-1.12%
RGEN	D	-1.04%
LH	F	-0.94%
TECH	F	-0.9%
RARE	D	-0.83%
INSM	D	-0.82%
NBIX	C	-0.76%
BMY	F	-0.71%
LGND	B	-0.69%
BIO	F	-0.67%
CDMO	F	-0.55%
AVTR	B	-0.52%
BBIO	F	-0.51%
UTHR	A	-0.49%
DVAX	D	-0.48%
SLP	A	-0.43%
ARE	C	-0.31%
DOCS	F	-0.29%
FTRE	B	-0.18%
OLK	D	-0.12%